SCHEMBL10070899

SCHEMBL10070899

CC/C=C\C/C=C\C/C=C\C/C=C\CC/C=C/C=C/C=O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 3/20 0.58
ALDH1A1 P00352 7/20 0.52
TSHR P16473 1/20 0.52
TRPA1 O75762 1/20 0.48
CYP19A1 P11511 4/20 0.45
PPARG P37231 3/20 0.45
OXER1 Q8TDS5 3/20 0.45
MAPT P10636 3/20 0.45
RXRA P19793 2/20 0.45
FFAR1 O14842 2/20 0.45
CNR1 P21554 2/20 0.45
CNR2 P34972 1/20 0.45
PTGS1 P23219 3/20 0.42
F7 P08709 3/20 0.42
F3 P13726 3/20 0.42
KMT2A Q03164 2/20 0.42
PPARD Q03181 2/20 0.42
ADORA3 P0DMS8 2/20 0.42
NR1I2 O75469 2/20 0.40
PTGS2 P35354 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4437779 0.93 ALDH1A1 (0.58) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL4437781 0.93 ALDH1A1 (0.58) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL13637803 0.93 ALDH1A1 (0.58) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL2744091 0.91 TRPA1 (0.59) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL2744358 0.91 TRPA1 (0.59) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL4664269 0.91 TRPA1 (0.59) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL887175 0.89 TRPA1 (0.55) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL5571559 0.89 TRPA1 (0.55) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL887174 0.89 TRPA1 (0.55) PPARAALDH1A1TSHRTRPA1CYP19A1
SCHEMBL21808897 0.89 TRPA1 (0.55) PPARAALDH1A1TSHRTRPA1CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120232143-A1 LIPID DERIVATIVES PRONOVA BIOPHARMA NORGE AS 2012-09-13 US disclosed
US-8178708-B2 Lipid derivatives PRONOVA BIOPHARMA NORGE AS (NO) 2012-05-15 US disclosed
US-20090105499-A1 LIPID DERIVATIVES PRONOVA BIOPHARMA NORGE AS (NO) 2009-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232143-A1 LIPID DERIVATIVES CYP4F3, STARD3, PLIN3 PPARA 802/4885ALDH1A1 1254/4885TSHR 1248/4885
US-20090105499-A1 LIPID DERIVATIVES PLIN3, STARD3, CYP4F3 PPARA 885/4885ALDH1A1 1511/4885TSHR 1564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.